157 related articles for article (PubMed ID: 1706114)
1. Characterization of a Plasmodium falciparum epitope recognized by a monoclonal antibody with broad isolate and species specificity.
Limpaiboon T; Taylor DW; Jones G; Geysen HM; Saul A
Southeast Asian J Trop Med Public Health; 1990 Sep; 21(3):388-96. PubMed ID: 1706114
[TBL] [Abstract][Full Text] [Related]
2. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
Burns JM; Majarian WR; Young JF; Daly TM; Long CA
J Immunol; 1989 Oct; 143(8):2670-6. PubMed ID: 2477452
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies.
Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ
Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a Plasmodium falciparum epitope recognized by a monoclonal antibody with broad isolate and species specificity.
Limpaiboon T; Taylor DW; Jones G; Geysen HM; Saul A
Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):284. PubMed ID: 1719648
[No Abstract] [Full Text] [Related]
5. A novel 70-kDa Triton X-114-soluble antigen of Plasmodium falciparum that contains interspecies-conserved epitopes.
Ma HW; Ray P; Dhanda V; Das PK; Paliwal S; Sahoo N; Patra KP; Das LK; Singh B; Kironde FA
Exp Parasitol; 1996 Aug; 83(3):322-34. PubMed ID: 8823249
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro.
Locher CP; Tam LQ; Chang SP; McBride JS; Siddiqui WA
Exp Parasitol; 1996 Oct; 84(1):74-83. PubMed ID: 8888734
[TBL] [Abstract][Full Text] [Related]
7. A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii.
Burns JM; Parke LA; Daly TM; Cavacini LA; Weidanz WP; Long CA
J Immunol; 1989 Apr; 142(8):2835-40. PubMed ID: 2467942
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody characterization of the 195-kilodalton major surface glycoprotein of Plasmodium falciparum malaria schizonts and merozoites: identification of additional processed products and a serotype-restricted repetitive epitope.
Lyon JA; Haynes JD; Diggs CL; Chulay JD; Haidaris CG; Pratt-Rossiter J
J Immunol; 1987 Feb; 138(3):895-901. PubMed ID: 2433334
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.
Sim BK; Carter JM; Deal CD; Holland C; Haynes JD; Gross M
Exp Parasitol; 1994 May; 78(3):259-68. PubMed ID: 7512929
[TBL] [Abstract][Full Text] [Related]
11. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.
Quakyi IA; Carter R; Rener J; Kumar N; Good MF; Miller LH
J Immunol; 1987 Dec; 139(12):4213-7. PubMed ID: 2447164
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
13. A protective merozoite protein of Plasmodium falciparum shares an epitope with surface antigens of Paramecium.
Sehgal A; Singh NJ; Chakraborty T; Sharma S
Parasite Immunol; 2004 May; 26(5):219-27. PubMed ID: 15491471
[TBL] [Abstract][Full Text] [Related]
14. Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum.
Anders RF; Brown GV; Coppel RL; Stahl HD; Bianco AE; Favaloro JM; Crewther PE; Culvenor JG; Kemp DJ
Dev Biol Stand; 1985; 62():81-9. PubMed ID: 2422079
[TBL] [Abstract][Full Text] [Related]
15. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum: analysis of the cytoadherence inhibition of the human monoclonal antibody 33G2 and of antibodies reactive with antigen Pf332.
Iqbal J; Perlmann P; Berzins K
Exp Parasitol; 1993 Aug; 77(1):79-87. PubMed ID: 8344409
[TBL] [Abstract][Full Text] [Related]
17. Novel monoclonal antibody against truncated C terminal region of Histidine Rich Protein2 (PfHRP2) and its utility for the specific diagnosis of malaria caused by Plasmodium falciparum.
Verma R; Jayaprakash NS; Vijayalakshmi MA; Venkataraman K
Exp Parasitol; 2015 Mar; 150():56-66. PubMed ID: 25592728
[TBL] [Abstract][Full Text] [Related]
18. Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum.
Koski GK; Ploton IN; Viscidi R; Kumar N
Pept Res; 1996; 9(3):127-35. PubMed ID: 8875592
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum complementary DNA clones expressed in Escherichia coli encode many distinct antigens.
Anders RF; Coppel RL; Brown GV; Saint RB; Cowman AF; Lingelbach KR; Mitchell GF; Kemp DJ
Mol Biol Med; 1984 Jun; 2(3):177-91. PubMed ID: 6399547
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
